Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 10, 2025 | CUTISS raises additional CHF 31 million to support ongoing Phase 3 trials | CUTISS’ personalized, bioengineered skin graft denovoSkin is designed for patients undergoing skin surgery for burns, reconstructive and plastic procedures. Long-term follow-ups to date have shown that it drastically spares donor sites, ma... |
| May 21, 2024 | CUTISS attracts CHF 25 million and enters Phase 3 clinical trials | CUTISS develops the first-in-class personalized and automated skin tissue therapy offering life-saving and life-changing medical treatments for patients with severe skin injuries globally. This first closing allows CUTISS to enter Phase 3 ... |
Reviews 0
FAQ about Shiloh Advisors AG
What has the press written about Shiloh Advisors AG?
Parsers VC has collected 3 articles mentioning Shiloh Advisors AG, among them “CUTISS raises additional CHF 31 million to support ongoing Phase 3 trials” (Sep 10, 2025) and “CUTISS attracts CHF 25 million and enters Phase 3 clinical trials” (May 21, 2024).
Is Shiloh Advisors AG still active?
Yes, Shiloh Advisors AG is active; its latest activity on Parsers VC dates from Sep 11, 2025.